Pembrolizumab for Refractory Metastatic Myxofibrosarcoma: A Case Report

Myxofibrosarcoma is a rare tumor, refractory to cytotoxic chemotherapy and radiotherapy. Pembrolizumab is an innovative immunotherapy drug consisting of programmed death receptor ligand 1 antibody proven to be useful for numerous types of cancer cells. A patient had been diagnosed with metastatic my...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Haa-Na, Kang, Min Gyu, Park, Jeong Rang, Hwang, Jin-Yong, Kang, Jung Hun, Lee, Won Seop, Lee, Gyeong-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192916/
https://www.ncbi.nlm.nih.gov/pubmed/29361819
http://dx.doi.org/10.4143/crt.2017.529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192916/
https://www.ncbi.nlm.nih.gov/pubmed/29361819
http://dx.doi.org/10.4143/crt.2017.529

Ejemplares similares